A method for preventing or treating hyperlipidemia includes administrating a composition consisting of a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract to a subject in need thereof. The composition may reduce an amounts of serum cholesterol and LDL-cholesterol and increase an amount of HDL-cholesterol, significantly reduce an amount of serum triglyceride compared with existing statin-based drugs, thereby exhibiting prophylactic and therapeutic effects of hyperlipidemia with various symptoms even without the co-administration of other drugs; and reduce an amounts of hepatic cholesterol and triglyceride, thereby exhibiting an effect of inhibiting fatty liver.

A method for preventing or treating hyperlipidemia includes administrating a composition consisting of a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract to a subject in need thereof. The composition may reduce an amounts of serum cholesterol and LDL-cholesterol and increase an amount of HDL-cholesterol, significantly reduce an amount of serum triglyceride compared with existing statin-based drugs, thereby exhibiting prophylactic and therapeutic effects of hyperlipidemia with various symptoms even without the co-administration of other drugs; and reduce an amounts of hepatic cholesterol and triglyceride, thereby exhibiting an effect of inhibiting fatty liver.

A method for preventing or treating hyperlipidemia includes administrating a composition consisting of a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract to a subject in need thereof. The composition may reduce an amounts of serum cholesterol and LDL-cholesterol and increase an amount of HDL-cholesterol, significantly reduce an amount of serum triglyceride compared with existing statin-based drugs, thereby exhibiting prophylactic and therapeutic effects of hyperlipidemia with various symptoms even without the co-administration of other drugs; and reduce an amounts of hepatic cholesterol and triglyceride, thereby exhibiting an effect of inhibiting fatty liver.

A method for preventing or treating hyperlipidemia includes administrating a composition consisting of a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract to a subject in need thereof. The composition may reduce an amounts of serum cholesterol and LDL-cholesterol and increase an amount of HDL-cholesterol, significantly reduce an amount of serum triglyceride compared with existing statin-based drugs, thereby exhibiting prophylactic and therapeutic effects of hyperlipidemia with various symptoms even without the co-administration of other drugs; and reduce an amounts of hepatic cholesterol and triglyceride, thereby exhibiting an effect of inhibiting fatty liver.

A method for preventing or treating hyperlipidemia includes administrating a composition consisting of a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract to a subject in need thereof. The composition may reduce an amounts of serum cholesterol and LDL-cholesterol and increase an amount of HDL-cholesterol, significantly reduce an amount of serum triglyceride compared with existing statin-based drugs, thereby exhibiting prophylactic and therapeutic effects of hyperlipidemia with various symptoms even without the co-administration of other drugs; and reduce an amounts of hepatic cholesterol and triglyceride, thereby exhibiting an effect of inhibiting fatty liver.

The present invention relates to a method for preventing, treating, and ameliorating a fatty liver disease in a person which may be a non-alcoholic liver disease or an alcoholic liver disease in the person. The method comprises administering to the person a therapeutic composition which is a pharmaceutical composition, a dietary supplement, a health functional food composition, and any combination thereof, wherein the therapeutic composition comprises an active ingredient which comprises a mixture of pharmaceutically acceptable solvent extracts of Hawthorn fruits and Salvia miltiorrhiza roots, and using the therapeutic composition administered to the person for preventing the fatty liver disease in the person. The ratio of the mixture of the solvent extracts of the Hawthorn fruits and the Salvia miltiorrhiza roots is selected over a range of ratios of between about 0.02 to about 50.

The present invention relates to a method for preventing, treating, and ameliorating a fatty liver disease in a person which may be a non-alcoholic liver disease or an alcoholic liver disease in the person. The method comprises administering to the person a therapeutic composition which is a pharmaceutical composition, a dietary supplement, a health functional food composition, and any combination thereof, wherein the therapeutic composition comprises an active ingredient which comprises a mixture of pharmaceutically acceptable solvent extracts of Hawthorn fruits and Salvia miltiorrhiza roots, and using the therapeutic composition administered to the person for preventing the fatty liver disease in the person. The ratio of the mixture of the solvent extracts of the Hawthorn fruits and the Salvia miltiorrhiza roots is selected over a range of ratios of between about 0.02 to about 50.

The present invention relates to a method for preventing, treating, and ameliorating a fatty liver disease in a person which may be a non-alcoholic liver disease or an alcoholic liver disease in the person. The method comprises administering to the person a therapeutic composition which is a pharmaceutical composition, a dietary supplement, a health functional food composition, and any combination thereof, wherein the therapeutic composition comprises an active ingredient which comprises a mixture of pharmaceutically acceptable solvent extracts of Hawthorn fruits and Salvia miltiorrhiza roots, and using the therapeutic composition administered to the person for preventing the fatty liver disease in the person. The ratio of the mixture of the solvent extracts of the Hawthorn fruits and the Salvia miltiorrhiza roots is selected over a range of ratios of between about 0.02 to about 50.

A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.

A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.